Axogen, Inc. Payments of Debt Issuance Costs
Axogen, Inc. (AXGN) reported Payments of Debt Issuance Costs of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2021-11-04
- Axogen, Inc. payments of debt issuance costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Axogen, Inc. payments of debt issuance costs for the quarter ending 2020-09-30 was $292.00K.
- Axogen, Inc. payments of debt issuance costs for the quarter ending 2017-12-31 was -$472.00.
- Axogen, Inc. payments of debt issuance costs for the quarter ending 2017-09-30 was $0.00.
- Axogen, Inc. payments of debt issuance costs for fiscal 2017 was $29.00K, a 96.38% decline from fiscal 2016.
- Axogen, Inc. payments of debt issuance costs for fiscal 2016 was $801.00K, a 344.66% increase from fiscal 2015.
- Axogen, Inc. payments of debt issuance costs for fiscal 2015 was $180.14K, a 78.04% decline from fiscal 2014.
- Axogen, Inc. payments of debt issuance costs for fiscal 2014 was $820.44K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month | Payments of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | ||||
| 2020-09-30 | $292.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $642.00K 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $350.00K 10-Q · filed 2021-08-05 | ||||
| 2017-12-31 | -$472.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$472.00 derived: sum of 2 quarters · filed 2019-02-26 | $2.57K derived: sum of 3 quarters · filed 2019-02-26 | $29.00K 10-K · filed 2019-02-26 | $29.47K 10-K · filed 2018-02-28 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $3.04K derived: sum of 2 quarters · filed 2018-10-29 | $29.47K 10-Q · filed 2018-10-29 | ||
| 2017-06-30 | $3.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $29.47K 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $26.43K 10-Q · filed 2018-04-30 | ||||
| 2016-12-31 | $801.00K 10-K · filed 2019-02-26 | $800.85K 10-K · filed 2017-03-01 | |||
| 2015-12-31 | -$3.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$3.00 derived: sum of 2 quarters · filed 2018-02-28 | -$3.00 derived: sum of 3 quarters · filed 2018-02-28 | $180.14K 10-K · filed 2018-02-28 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $180.14K 10-Q · filed 2016-11-02 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $180.14K 10-Q · filed 2016-08-03 | |||
| 2015-03-31 | $180.14K 10-Q · filed 2016-05-04 | ||||
| 2014-12-31 | $820.44K 10-K · filed 2016-02-29 | ||||
| 2012-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $1.29M derived: sum of 2 quarters · filed 2014-03-06 | $1.31M 10-K · filed 2014-03-06 | ||
| 2012-09-30 | $101.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $118.48K 10-Q · filed 2013-10-30 | |||
| 2012-06-30 | $16.70K 10-Q · filed 2013-08-14 | ||||
| 2011-12-31 | $132.99K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $352.43K derived: sum of 2 quarters · filed 2013-08-07 | $397.43K derived: sum of 3 quarters · filed 2013-08-07 | $434.77K 10-K/A · filed 2013-08-07 | |
| 2011-09-30 | $219.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $264.43K derived: sum of 2 quarters · filed 2012-11-06 | $301.78K 10-Q · filed 2012-11-06 | $355.71K derived: sum of 4 quarters · filed 2012-11-06 | |
| 2011-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $82.35K 10-Q · filed 2012-08-14 | $136.28K derived: sum of 3 quarters · filed 2012-08-14 | ||
| 2011-03-31 | $37.35K 10-Q · filed 2012-05-15 | $91.28K derived: sum of 2 quarters · filed 2012-05-15 | |||
| 2010-12-31 | $53.93K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $150.05K 10-K · filed 2012-03-15 | |||
| 2010-09-30 | $96.12K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |